Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
•
General Neurology
How can we minimize the risk of overinterpreting reactive findings from repeat lumbar punctures?
e.g. reactive pleiocytosis, in light of publication from
Schimdauer et al in Eur J Neurol 2025 Apr
Related Questions
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
At what degree of lymphopenia do you switch/discontinue dimethyl fumarate in patients with multiple sclerosis?
When do you consider pembrolizumab for the treatment of progressive multifocal leukoencephalopathy?
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?
How do you counsel women on anti-CD20 therapy for MS who are planning for pregnancy?
How do you decide on long term immunosuppression therapy for Susac Syndrome?
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
What is your disease modifying treatment of choice for a patient with relapsing remitting multiple sclerosis with treated, well controlled HIV?
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
Would you proceed with anti-CD20 treatment in an MS patient who is VZV IgG negative in spite of vaccination in the last year?